Chennai Meenakshi Multispeciality Hospital reshuffles board, approves CEO fees
- CEO Dr. Thanigai Vendan Moorthy approved for up to ₹96 lakh annual professional fees in FY27
- Two independent directors redesignated as non-independent and liable to retire by rotation
- Mrs. R. Gomathi re-appointed as Managing Director for three years until November 2029
- Board committees reconstituted following changes in director designations
- 36th AGM scheduled for September 30, 2026, via video conferencing
*this image is generated using AI for illustrative purposes only.
Chennai Meenakshi Multispeciality Hospital Ltd has restructured its board composition and approved a professional fee arrangement for its chief executive officer. The changes were approved during a board meeting held on September 1, 2026.
The board approved a fixed professional consultancy fee of ₹3,00,000 per month and a variable surgical fee of up to ₹5,00,000 per month for Dr. Thanigai Vendan Moorthy, CEO and Key Managerial Personnel. This brings the maximum aggregate payment to ₹8,00,000 per month or ₹96,00,000 per annum for FY27. These fees are separate from his executive remuneration and are payable against actual services rendered on an arm's length basis.
Board Composition Changes
Two non-executive independent directors were redesignated as non-executive non-independent directors effective September 1, 2026. Mr. A. F. Simeon Telfer and Ms. Sindu Chawla will now be liable to retire by rotation. The company stated this change follows an assessment of its overall board structure and skills requirements.
The board also recommended the re-appointment of Mr. Edward M. Prabhakar as a non-executive director liable to retire by rotation. His appointment is subject to shareholder approval via an ordinary resolution at the 36th Annual General Meeting (AGM).
Additionally, the board approved the re-appointment of Mrs. R. Gomathi as Managing Director for three consecutive years, from November 11, 2026, to November 10, 2029. She will receive a consolidated salary of ₹1,00,000 per month with no perquisites. Her re-appointment requires a special resolution from shareholders, as she has attained the age of 70 years.
Committee Reconstitution
Consequent to the director redesignations, the company reconstituted its statutory committees:
- Audit Committee: Mr. M. Karunakaran (Chairman), Mrs. Shama Dhilip (Member), Mrs. Jayanthi Radhakrishnan (Member)
- Nomination and Remuneration Committee: Mrs. Shama Dhilip (Chairperson), Mr. R. V. Ramanuja Bharathi (Member), Mr. Akash Prabhakar (Member)
- Stakeholders' Relationship Committee: Mr. R. V. Ramanuja Bharathi (Chairman), Mr. M. Karunakaran (Member), Mr. Edward Prabhakar (Member)
AGM Details
The company scheduled its 36th AGM for September 30, 2026, at 11:00 am via video conferencing. The book closure period runs from September 24, 2026, to September 30, 2026, inclusive. The notice for the meeting has been authorized for issuance.
Historical Stock Returns for Chennai Meenakshi Multispeciality
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +3.73% | +4.02% | -1.34% | -1.32% | 0.0% |
How might the shift of two independent directors to non-independent status impact Chennai Meenakshi's corporate governance ratings and investor confidence?
What are the potential implications for the hospital's operational strategy given the CEO's new variable surgical fee structure tied to actual services rendered?
Will shareholders approve the special resolution required for Mrs. R. Gomathi's re-appointment as Managing Director despite her being over 70 years old?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
